From Micro to "Extreme Minimally Invasive": How China's Single-Port Robot Takes the Global Lead

Recently, the Toumai® single-port and multi-port laparoscopic surgical robots independently developed by Shanghai MicroPort MedBot Group have completed commercial installation at Cleveland Clinic Abu Dhabi, an institution renowned as one of the "Twin Stars of American Medicine". This marks the first time a Chinese domestic surgical robot has obtained access qualification from a world-class top-tier medical institution, signifying that China's intelligent manufacturing has officially stepped onto the golden stage of global minimally invasive surgery.

As a benchmark institution in the global medical field, Cleveland Clinic served 3.5 million patients from 113 countries and regions in the previous year, with an annual surgical volume reaching 320,000 cases. It has always been at the global forefront in the application and promotion of robot-assisted surgery. Its overseas flagship, Cleveland Clinic Abu Dhabi, is the most influential high-end medical institution in the Middle East, with extremely stringent evaluation criteria for surgical robots, which focus on the equipment's stability, reliability and actual clinical efficacy in high-difficulty complex surgeries.

The Toumai single-port robot was officially stationed at the hospital earlier this year. After more than half a year of clinical use, the hospital's clinical team gave high praise: the Toumai robot features precise operation and stable performance, with clinical maturity and academic support system fully comparable to top international brands. Its unique integrated force sensing component and remote surgery capability even became the core advantages that helped it stand out in the head-to-head competition with other well-known global surgical robot products.

Technical Hard Power — The Single-Port Breakthrough from "Minimally Invasive" to "Extreme Minimally Invasive"

The Toumai single-port laparoscopic surgical robot is the only one in China and the second in the world equipped with the "mechanical fixed-point" technology. It represents the cutting-edge direction of global minimally invasive surgery: it can complete complex multi-instrument operations through only a single incision, which not only greatly reduces surgical trauma and speeds up postoperative recovery, but also takes into account postoperative cosmetic appearance. This marks that surgery has officially advanced from traditional "minimally invasive" to a brand-new stage of "extreme minimally invasive".

In February this year, the Toumai single-port robot was officially approved for marketing by the National Medical Products Administration of China, with its clinical application scope covering multiple departments including urology, general surgery and gynecology. Together with the Toumai multi-port laparoscopic surgical robot, the DragonFly® 3D electronic laparoscopic endoscope and the remote surgery system, it forms an integrated intelligent laparoscopic surgical solution, directly elevating the overall level of laparoscopic robotic surgery in China to a new height.

In the clinical implementation at Cleveland Clinic Abu Dhabi, this Chinese domestic surgical robot has successfully been applied in typical single-port procedures in urology and other departments, relying on its excellent hand-eye coordination, flexibility and precision beyond human hands, immersive 3D stereoscopic vision and smooth "human-machine integrated" operation experience. It has provided a brand-new technical support and clinical model for the hospital's minimally invasive surgery system.

Accelerated Global Expansion — 50+ Overseas Orders, Covering Over 30 Countries Across Four Continents

Today, China's intelligently manufactured surgical robots have long gone global with their outstanding technical strength. In the first half of this year, the cumulative overseas orders for the Toumai single-port and multi-port surgical robots have exceeded 50 units, covering more than 30 countries and regions across Asia, Europe, Africa and South America. Dozens of well-known hospitals in Italy, Belgium, Georgia, Kuwait, Morocco, India, Angola, Chile, Brazil, Argentina and other countries have incorporated this advanced surgical robot from China into their routine clinical practice. From mature European and American markets to emerging economies, the footprint of Chinese surgical robots is extending at an astonishing speed, with its technical reliability and clinical cost-effectiveness increasingly widely recognized by the global surgical community.

This in-depth cooperation with Cleveland Clinic Abu Dhabi has further turned this top international medical institution into a global "showcase window" for Chinese domestic surgical robots. It will generate a strong demonstration effect for hospitals in the Middle East, Europe, North Africa and North America, further enhancing the global brand awareness, academic influence and technical recognition of Chinese surgical robots. In the future, the two sides will also jointly explore the formulation of cross-border collaboration standards for robotic surgery, the construction of an international remote surgery network and relevant surgical education and training, to promote the overall progress of global minimally invasive surgery.

Opening Doors for Global Patients — DOVECURE Medical Escort Platform Safeguards Your Medical Journey in China

A growing number of patients around the world are turning their attention to China's cutting-edge medical resources, hoping to experience the benefits brought by China's advanced minimally invasive medical technology. The high cost-effective medical services and cutting-edge technical advantages of Chinese hospitals are attracting a rising number of overseas medical demands. However, the cross-language and cross-regional medical procedures often become an invisible threshold for international patients to access China's high-quality medical care.

Against this backdrop, DOVECURE Medical Escort Platform came into being, a one-stop full-process medical service platform specially built for overseas patients seeking medical treatment in China. The platform connects global patients with top-tier Chinese hospitals, leading disciplines, authoritative experts and cutting-edge medical technologies, providing a full-cycle and fully closed-loop medical service from remote assessment, medical escort in China, refined diagnosis and treatment to post-discharge follow-up after returning home.

From pre-trip visa assistance, airport pickup and drop-off services, flight and hotel booking, to precise appointment registration, full-process bilingual medical escort and care, professional medical record and report translation during the treatment, the platform breaks through all barriers in the medical journey in China. More thoughtfully, it also provides customized extended services including premium experience tourism and traditional Chinese medicine wellness tourism after treatment.

From being a follower in the past to now standing in the first echelon of global minimally invasive surgery, the Toumai surgical robot and other similar Chinese medical technologies are demonstrating the hard power of "China's intelligent manufacturing" to the world. Supporting service forces like DOVECURE Medical Escort Platform make this technical dividend truly accessible — bringing global patients safer, more precise and more minimally invasive new treatment options, and allowing the warmth and professionalism of Chinese medical care to cross national borders and reach every distant guest in need.